NRX Pharmaceuticals Inc.(NRXP)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

NRXP NRX Pharmaceuticals Inc.

交易中 05-14 13:22:31 EDT

3.18

+0.19

+6.35%

最高3.18	最低2.94	成交量12.63万
今开3.01	昨收2.99	日振幅8.03%
总市值3,314万	流通市值2,413万	总股本1,042万
成交额38.74万	换手率1.66%	流通股本758.81万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"NRXP","market":"US","secType":"STK","nameCN":"NRX Pharmaceuticals Inc.","latestPrice":3.18,"timestamp":1715707344002,"preClose":2.99,"halted":0,"volume":126304,"delay":0,"floatShares":7588129,"shares":10421401,"eps":-3.980768,"marketStatus":"交易中","marketStatusCode":2,"change":0.19,"latestTime":"05-14 13:22:31 EDT","open":3.01,"high":3.18,"low":2.94,"amount":387381.9715008,"amplitude":0.080268,"askPrice":3.19,"askSize":645,"bidPrice":3.15,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-3.980768,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1715716800000},"adr":0,"adjPreClose":2.99,"preHourTrading":{"tag":"盘前","latestPrice":2.9214,"preClose":2.99,"latestTime":"09:24 EDT","volume":1155,"amount":3449.8423575,"timestamp":1715693085207},"postHourTrading":{"tag":"盘后","latestPrice":2.97,"preClose":2.99,"latestTime":"19:57 EDT","volume":2577,"amount":7668.6486,"timestamp":1715644640866},"volumeRatio":0.407889},"requestUrl":"/m/hq/s/NRXP/tweets","defaultTab":"tweets","newsList":[{"id":"2434899083","title":"NRX Pharmaceuticals Inc    预计每股亏损 55 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2434899083","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2434899083?lang=zh_cn&edition=full","pubTime":"2024-05-11 04:38","pubTimestamp":1715373521,"startTime":"0","endTime":"0","summary":"   * NRX Pharmaceuticals Inc    预计将于5月14日公布截至2024年3月31日的财报。*    * LSEG分析师对NRX Pharmaceuticals Inc的平均预期是每股亏损55美分。* 目前，分析师对该公司股票的平均评级为 \"买入\"，建议分类为 2 个 \"强烈买入 \"或 \"买入\"，没有 \"持有\"，也没有 \"卖出 \"或 \"强烈卖出\"。* 华尔街对 NRX Pharmaceuticals Inc 的 12 个月目标价中位数为 35.00 美元，高于其上一次收盘价 2.93 美元。5月10日 - 本摘要于北京时间 5 月 10 日 20:38 机器生成。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2422621624","title":"NRX Pharmaceuticals Inc    预计每股亏损 7 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2422621624","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2422621624?lang=zh_cn&edition=full","pubTime":"2024-03-27 04:24","pubTimestamp":1711484663,"startTime":"0","endTime":"0","summary":"   * NRX Pharmaceuticals Inc    预计将于3月28日公布截至2023年12月31日的财报。*    * LSEG的分析师平均预计NRX Pharmaceuticals Inc每股亏损7美分。* 华尔街对 NRX Pharmaceuticals Inc 的 12 个月目标价中位数为 2.00 美元，高于上一次 0.53 美元的收盘价。3月26日 - 上一季度业绩。除非另有说明，所有数字均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2404899463","title":"BUZZ--美国股票走势-Halozyme、Scorpio Tankers、AMD(超威/超微)","url":"https://stock-news.laohu8.com/highlight/detail?id=2404899463","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2404899463?lang=zh_cn&edition=full","pubTime":"2024-01-17 00:02","pubTimestamp":1705420962,"startTime":"0","endTime":"0","summary":"        *      个股走势的 Eikon 搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      1月16日 - 华尔街主要股指周二下跌，原因是高盛和摩根士丹利的财报喜忧参半，令投资者对资本市场和交易的健康状况持谨慎态度，银行股因此承压，而特斯拉和苹果的下跌也对股指造成了影响。美东时间 10:37，道琼斯工业平均指数  下跌 0.37%，报 37,452.44 点。标普500指数  和纳斯达克综合指数  下跌0.11%，报14,956.264点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2403850362","title":"BUZZ-NRx Pharma 因泌尿感染治疗药物获得 FDA \"快速通道 \"标签而攀升","url":"https://stock-news.laohu8.com/highlight/detail?id=2403850362","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2403850362?lang=zh_cn&edition=full","pubTime":"2024-01-16 20:00","pubTimestamp":1705406405,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    1月16日 - ** NRx制药公司  股价盘前上涨2.8%至44美分** 美国 FDA 授予 NRx 治疗尿路感染的药物 \"快速通道 \"称号** NRx 称，NRX-101 疗法在 FDA 审查中显示出对耐药尿路病原体的强大活性** 快速通道 \"资格旨在加快对为治疗严重疾病而开发的候选药物的审查速度** 2023 年股价下跌 58.6","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.nrxpharma.com","stockEarnings":[{"period":"1week","weight":-0.0229},{"period":"1month","weight":-0.416},{"period":"3month","weight":-0.4019},{"period":"6month","weight":-0.08},{"period":"1year","weight":-0.5254},{"period":"ytd","weight":-0.35}],"compareEarnings":[{"period":"1week","weight":0.0084},{"period":"1month","weight":0.0197},{"period":"3month","weight":0.0543},{"period":"6month","weight":0.1584},{"period":"1year","weight":0.2656},{"period":"ytd","weight":0.0959}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"NRX Pharmaceuticals, Inc.是于2015年5月20日依照特拉华州法律成立的公司，是一家临床阶段的小分子制药公司，开发用于治疗中枢神经系统疾病和危及生命的肺部疾病的新型疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.17342},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.0504},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.073314},{"month":4,"riseRate":0,"avgChangeRate":-0.311577},{"month":5,"riseRate":0.666667,"avgChangeRate":-0.092697},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.236175},{"month":7,"riseRate":0.666667,"avgChangeRate":0.144953},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.129866},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.130012},{"month":10,"riseRate":1,"avgChangeRate":0.145789},{"month":11,"riseRate":0.666667,"avgChangeRate":0.165222},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.058796}],"exchange":"NASDAQ","name":"NRX Pharmaceuticals Inc.","nameEN":"NRX Pharmaceuticals Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"NRX Pharmaceuticals Inc.(NRXP)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供NRX Pharmaceuticals Inc.(NRXP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"NRX Pharmaceuticals Inc.,NRXP,NRX Pharmaceuticals Inc.股票,NRX Pharmaceuticals Inc.股票老虎,NRX Pharmaceuticals Inc.股票老虎国际,NRX Pharmaceuticals Inc.行情,NRX Pharmaceuticals Inc.股票行情,NRX Pharmaceuticals Inc.股价,NRX Pharmaceuticals Inc.股市,NRX Pharmaceuticals Inc.股票价格,NRX Pharmaceuticals Inc.股票交易,NRX Pharmaceuticals Inc.股票购买,NRX Pharmaceuticals Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"NRX Pharmaceuticals Inc.(NRXP)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供NRX Pharmaceuticals Inc.(NRXP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况